Home » Stocks » TCDA

Tricida, Inc. (TCDA)

Stock Price: $4.06 USD 0.11 (2.78%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 198.58M
Revenue (ttm) n/a
Net Income (ttm) -264.79M
Shares Out 50.03M
EPS (ttm) -5.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $4.06
Previous Close $3.95
Change ($) 0.11
Change (%) 2.78%
Day's Open 3.98
Day's Range 3.96 - 4.23
Day's Volume 238,884
52-Week Range 3.74 - 32.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Webcast Today at 4:30 pm Eastern Time Webcast Today at 4:30 pm Eastern Time

1 day ago - GlobeNewsWire

Webcast Today at 4:30 pm Eastern Time Webcast Today at 4:30 pm Eastern Time

1 day ago - GlobeNewsWire

SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2021 financial results after the close of market on Thu...

1 week ago - GlobeNewsWire

Tricida (TCDA) has been struggling lately, but the selling pressure may be coming to an end soon

2 weeks ago - Zacks Investment Research

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, Apr...

4 weeks ago - GlobeNewsWire

SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candid...

1 month ago - GlobeNewsWire

After previously exiting a position in the fourth quarter of 2020, Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a new 5.03% stake in Tricida Inc. (NASDAQ:TCDA) earlier this...

Other stocks mentioned: AZN, BHC, BIIB, BMY, LLY, MRK
1 month ago - GuruFocus

NEW YORK, March 8, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class actio...

1 month ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 8, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2...

1 month ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA) and certain of...

2 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tri...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 6, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that t...

2 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 5, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tr...

2 months ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $TCDA #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tricida, Inc. (TCDA)

2 months ago - Business Wire

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ...

2 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...

2 months ago - Newsfile Corp

LOS ANGELES, March 4, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming March 8, 2021 deadline to file a lead plaintiff motion in the class action filed on behal...

2 months ago - PRNewsWire

NEW YORK, March 3, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 and October...

2 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 3, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that t...

2 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 3, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tr...

2 months ago - Newsfile Corp

Extends Veverimer Patent Protection into 2038 Extends Veverimer Patent Protection into 2038

2 months ago - GlobeNewsWire

NEW YORK, March 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA) and certain of its officers. ...

2 months ago - PRNewsWire

Investors with losses are encouraged to contact the firm before March 8, 2021; click here to submit trade information

2 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that t...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 1, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tri...

2 months ago - Newsfile Corp

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ...

2 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - February 27, 2021) - WHY: New York, N.Y., February 27, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc...

2 months ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

2 months ago - Newsfile Corp

The FDA denied the biotech's appeal, but there's still a path forward for its drug.

2 months ago - The Motley Fool

Tricida Inc (NASDAQ: TCDA) has received an Appeal Denied Letter (ADL) from the Office of New Drugs (OND) of the FDA in response to the company's Formal Dispute Resolution Request (FDRR) submitted in Dec...

2 months ago - Benzinga

New York, New York--(Newsfile Corp. - February 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...

2 months ago - Newsfile Corp

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Nationally-recognized securities law firm Block & Leviton LLP (www.blockleviton.com) announces that a lawsuit for violation of the federal securities laws has b...

2 months ago - GlobeNewsWire

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candida...

2 months ago - GlobeNewsWire

Tricida Has Received an Appeal Denied Letter from the Office of New Drugs of the FDA in Response to its Formal Dispute Resolution Request Tricida Has Received an Appeal Denied Letter from the Office of ...

2 months ago - GlobeNewsWire

LOS ANGELES, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 8 , 2021  deadline to file a lead plaintiff motion in the class action filed on...

2 months ago - GlobeNewsWire

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockh...

Other stocks mentioned: LIZI, PEN, QS
2 months ago - GlobeNewsWire

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class a...

2 months ago - GlobeNewsWire

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) and certain ...

2 months ago - Business Wire

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 and Oct...

2 months ago - GlobeNewsWire

Los Angeles, California--(Newsfile Corp. - February 23, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. (...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - February 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging th...

2 months ago - Newsfile Corp

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded ...

Other stocks mentioned: GTT
2 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - February 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - February 22, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. (NASDAQ: TCDA) ("Tricida" or the "Company") and certai...

2 months ago - Newsfile Corp

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its fourth quarter and year-end 2020 financial results after the close of ...

2 months ago - GlobeNewsWire

BENSALEM, Pa., Feb. 22, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming March 8, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of invest...

2 months ago - PRNewsWire

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of   Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 an...

2 months ago - GlobeNewsWire

About TCDA

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jun 28, 2018
CEO
Gerrit Klaerner
Employees
64
Stock Exchange
NASDAQ
Ticker Symbol
TCDA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Tricida stock is "Buy." The 12-month stock price forecast is 15.33, which is an increase of 277.59% from the latest price.

Price Target
$15.33
(277.59% upside)
Analyst Consensus: Buy